Regional brain atrophy predicts time to conversion to Alzheimer's disease, dependent on baseline volume

Albert, 2011, The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease, Alzheimers Dement., 7, 270, 10.1016/j.jalz.2011.03.008 Braak, 1991, Neuropathological stageing of Alzheimer-related changes, Acta Neuropathol., 82, 239, 10.1007/BF00308809 Braak, 1997, Frequency of stages of Alzheimer-related lesions in different age categories, Neurobiol. Aging, 18, 351, 10.1016/S0197-4580(97)00056-0 Byun, 2015, Heterogeneity of regional brain atrophy patterns associated with distinct progression rates in Alzheimer's disease, PLoS One, 10, e0142756, 10.1371/journal.pone.0142756 Douaud, 2013, Preventing Alzheimer’s disease-related gray matter atrophy by B-vitamin treatment, Proc. Natl. Acad. Sci. U. S. A., 110, 9523, 10.1073/pnas.1301816110 Dubois, 2015, Donepezil decreases annual rate of hippocampal atrophy in suspected prodromal Alzheimer's disease, Alzheimers Dement., 11, 1041, 10.1016/j.jalz.2014.10.003 Dubois, 2016, Preclinical Alzheimer's disease: definition, natural history, and diagnostic criteria. Alzheimer's & dementia, J. Alzheimers Assoc., 12, 292, 10.1016/j.jalz.2016.02.002 Falahati, 2017, Monitoring disease progression in mild cognitive impairment: associations between atrophy patterns, cognition, APOE and amyloid, Neuroimage Clin., 16, 418, 10.1016/j.nicl.2017.08.014 Ferreira, 2017, Distinct subtypes of Alzheimer's disease based on patterns of brain atrophy: longitudinal trajectories and clinical applications, Sci. Rep., 7, 46263, 10.1038/srep46263 Fjell, 2014, Accelerating cortical thinning: unique to dementia or universal in aging?, Cereb. Cortex, 24, 919, 10.1093/cercor/bhs379 Gavidia-Bovadilla, 2017, Early prediction of Alzheimer's disease using null longitudinal model-based classifiers, PLoS One, 12, e0168011, 10.1371/journal.pone.0168011 Jack, 2018, NIA-AA Research Framework: toward a biological definition of Alzheimer's disease, Alzheimers Dement., 14, 535, 10.1016/j.jalz.2018.02.018 Jack, 2008, The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods, J. Magn. Reson. Imaging, 27, 685, 10.1002/jmri.21049 Jack, 2005, Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI, Neurology, 65, 1227, 10.1212/01.wnl.0000180958.22678.91 Kile, 2017, IVIG treatment of mild cognitive impairment due to Alzheimer's disease: a randomised double-blinded exploratory study of the effect on brain atrophy, cognition and conversion to dementia, J. Neurol. Neurosurg. Psychiatry, 88, 106, 10.1136/jnnp-2015-311486 Kobe, 2016, Combined omega-3 fatty acids, aerobic exercise and cognitive stimulation prevents decline in gray matter volume of the frontal, parietal and cingulate cortex in patients with mild cognitive impairment, Neuroimage, 131, 226, 10.1016/j.neuroimage.2015.09.050 Li, 2012, Discriminant analysis of longitudinal cortical thickness changes in Alzheimer's disease using dynamic and network features, Neurobiol. Aging, 33, 427.e15, 10.1016/j.neurobiolaging.2010.11.008 Liu, 2017, Prediction of mild cognitive impairment conversion using a combination of independent component analysis and the Cox model, Front Hum. Neurosci., 11, 33, 10.3389/fnhum.2017.00033 McEvoy, 2011, Mild cognitive impairment: baseline and longitudinal structural MR imaging measures improve predictive Prognosis1, Radiology, 259, 834, 10.1148/radiol.11101975 Murray, 2011, Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study, Lancet Neurol., 10, 785, 10.1016/S1474-4422(11)70156-9 Petersen, 2010, Alzheimer's disease neuroimaging initiative (ADNI) clinical characterization, Neurology, 74, 201, 10.1212/WNL.0b013e3181cb3e25 Pintzka, 2015, Marked effects of intracranial volume correction methods on sex differences in neuroanatomical structures: a HUNT MRI study, Front Neurosci., 9, 238, 10.3389/fnins.2015.00238 Prins, 2014, The effect of galantamine on brain atrophy rate in subjects with mild cognitive impairment is modified by apolipoprotein E genotype: post-hoc analysis of data from a randomized controlled trial, Alzheimers Res. Ther., 6, 47, 10.1186/alzrt275 Risacher, 2009, Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort, Curr. Alzheimer Res., 6, 347, 10.2174/156720509788929273 Risacher, 2010, Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort, Neurobiol. Aging, 31, 1401, 10.1016/j.neurobiolaging.2010.04.029 Tabatabaei-Jafari, 2015, Cerebral atrophy in mild cognitive impairment: a systematic review with meta-analysis, Alzheimers Dement., 1, 487 Tabatabaei-Jafari, 2019, Cognitive/functional measures predict Alzheimer's disease, dependent on hippocampal volume, J. Gerontol. B Psychol. Sci. Soc. Sci., 10.1093/geronb/gbz011 Teipel, 2015, The relative importance of imaging markers for the prediction of Alzheimer's disease dementia in mild cognitive impairment - beyond classical regression, Neuroimage Clin., 8, 583, 10.1016/j.nicl.2015.05.006 Thal, 2002, Phases of A beta-deposition in the human brain and its relevance for the development of AD, Neurology, 58, 1791, 10.1212/WNL.58.12.1791 Thung, 2018, Conversion and time-to-conversion predictions of mild cognitive impairment using low-rank affinity pursuit denoising and matrix completion, Med. Image Anal., 45, 68, 10.1016/j.media.2018.01.002 Whitwell, 2012, Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: a case-control study, Lancet Neurol., 11, 868, 10.1016/S1474-4422(12)70200-4 Whitwell, 2007, 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease, Brain., 130, 1777, 10.1093/brain/awm112 Zhang, 2017, Effects of DHA supplementation on hippocampal volume and cognitive function in older adults with mild cognitive impairment: a 12-month randomized, double-blind, placebo-controlled trial, J. Alzheimers Dis., 55, 497, 10.3233/JAD-160439